Your current location:HOME >travel >Why Amylyx is pulling ALS drug Relyvrio from US market after study 正文
TIME:2024-05-21 10:53:29 Source: Internet compilationEdit:travel
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
US overdose deaths dropped in 2023, the first time since 20182024-05-21 10:41
China's State Council to revise, repeal administrative regulations2024-05-21 10:35
CPPCC member advocates for legislation on AI law2024-05-21 10:03
Kenya holds China alumni symposium on Belt and Road Initiative2024-05-21 10:01
Analysis: Larson enters conversation with Verstappen as best drivers in the world2024-05-21 09:37
Mexico evacuates 34 citizens from violence2024-05-21 09:29
UN Security Council adopts resolution demanding cease2024-05-21 09:04
Rwanda makes progress in fight against tuberculosis: official2024-05-21 08:47
Storms damage homes in Oklahoma and Kansas. But in Houston, most power is restored2024-05-21 08:39
6 North Sea nations to jointly protect offshore infrastructure2024-05-21 08:25
Kristin Cavallari, 37, ignores critics of her age2024-05-21 10:37
China to enhance employment services for veterans2024-05-21 10:34
UN Security Council adopts resolution demanding cease2024-05-21 10:25
HK deputies urge for linking GBA's finance, healthcare and sports sectors2024-05-21 10:17
Verona confirms Serie A status for another year after beating Salernitana2024-05-21 10:01
Four people charged in the case of 2 women missing from Oklahoma2024-05-21 09:35
Iraq signs MoU with German, U.S. companies on associated gas utilization2024-05-21 09:15
Chengdu Universiade2024-05-21 08:26
Lynn Williams breaks NWSL goal2024-05-21 08:23
China to enhance employment services for veterans2024-05-21 08:06